Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOTICGeneric

TRIDESILON

ACETIC ACID, GLACIAL; DESONIDE

Standard Dose
2%;0.05%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TRIDESILON is listed in Drugs@FDA under application 017914 (NDA).

Marketing status: Discontinued Active ingredient ACETIC ACID, GLACIAL; DESONIDE Form and strength SOLUTION/DROPS;OTIC - 2%;0.05% Sponsor BAYER PHARMS Submission history Latest submission status date: 1997-07-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIDESILON is listed in Drugs@FDA under application 017914 (NDA). Marketing status: Discontinued Active ingredient ACETIC ACID, GLACIAL; DESONIDE Form and strength SOLUTION/DROPS;OTIC - 2%;0.05% Sponsor BAYER PHARMS Submission history Latest submission status date: 1997-07-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.